Oxurion NV
XBRU:OXUR

Watchlist Manager
Oxurion NV Logo
Oxurion NV
XBRU:OXUR
Watchlist
Price: 0.28 EUR Market Closed
Market Cap: 374.2k EUR
Have any thoughts about
Oxurion NV?
Write Note

EV/EBIT
Enterprise Value to EBIT

-0
Current
-0.2
Median
4.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-0
=
Enterprise Value
258.7k EUR
/
EBIT
-7.4m EUR
All Countries
Close
Market Cap EV/EBIT
BE
Oxurion NV
XBRU:OXUR
343.7k EUR -0
FR
Pharnext SCA
OTC:PNEXF
6T USD -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.1B USD 24.1
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 31.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD 26.3
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 10
US
Epizyme Inc
F:EPE
94.1B EUR -504.1
AU
CSL Ltd
ASX:CSL
135.4B AUD 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 18.1
US
Seagen Inc
F:SGT
39.3B EUR -53.4
NL
argenx SE
XBRU:ARGX
34.5B EUR -76.6
EBIT Growth
BE
Oxurion NV
XBRU:OXUR
Average EV/EBIT: 22.6
Negative Multiple: -0
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.8
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A

See Also

Discover More